Name: Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis (Video) | JoVE Journal
Uploaded: 2016-11-14T13:00:00.000+00:00
Duration: 8 min 11 s
Description: Learn to assess progressive neurological disability in mice using an optimized Rotarod test protocol. This method provides objective quantification of motor function in the Theilers virus model of multiple sclerosis.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors thank the staff of the Center for Comparative Medicine and Research (CCMR) at Dartmouth for their expert care of the mice used for these studies. The authors also acknowledge Emily Clough for her excellent administrative support.

All animal work utilizes protocols reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at Geisel School of Medicine at Dartmouth.
1. The Mouse Model
<ol>
	<li>Induction of TMEV-Induced Demyelinating Disease
	<ol>
		<li>Move the cages containing 4- to 6-week-old female SJL/JHan mice from the rack to a comfortable working space. Mark the mice (e.g., with an ear tag or ear punch) to allow for individual evaluation of clinical and histological disease.</li>
		<li>Draw 30 &#956;l of TMEV infecting stock (2 x 106 plaque forming units; PFU) in PBS into a 29-gauge insulin syringe and needle.</li>
		<li>Prepare the anesthesia gas machine: check the system to ensure the presence of adequate amounts of oxygen and isoflurane for the duration of the procedure.</li>
		<li>Turn on the flow meter to 1 L/min. Place the animal into the induction chamber and seal the top. Turn on the vaporizer to 3.5% and monitor the animal until recumbent.</li>
		<li>Remove the animal from the chamber and test the mouse by pinching the footpad to ensure adequate anesthesia. Lack of response to a strong pinch indicates adequate anesthesia.</li>
		<li>Clean the injection site with 70% isopropyl alcohol.</li>
		<li>Inject the 30 &#956;l of TMEV infecting stock into the right cerebral hemisphere by freehand injection (Figure 1). The site of injection is approximately halfway between the eye and ear line and just off the midline.</li>
		<li>Return the mouse to its holding cage once fully alert and mobile (usually 3 - 5 min).</li>
		<li>Euthanize mice by exsanguination or cardiac perfusion 3 to 6 months after TMEV infection, depending on the rapidity of development of the disease.</li>
	</ol>
	</li>
</ol>
2. Rotarod Analysis
<ol>
	<li>The Rotarod Apparatus
	<ol>
		<li>Test mice prior to TMEV infection to familiarize them with the machine and to assess their normal baseline balance coordination and motor control.</li>
		<li>Start the adaptation protocol on -5 days post infection (dpi; i.e., 5 days before TMEV infection).</li>
		<li>Allow the mice to acclimate to the testing room for at least 30 min prior to Rotarod testing, in order to allow them to adjust to the environment.</li>
		<li>Make sure that both the Rotarod unit and the computer are plugged in and connected to each other (Figure 2).</li>
		<li>Pre-set the Rotarod with the -5 dpi training protocol parameters, as described in Table 1.</li>
		<li>Save the work file with the date and identification information.</li>
		<li>Move the cage containing the squad to be tested from the rack to a table adjacent to the Rotarod. Mice are usually tested in squads of 4.</li>
		<li>Pick up a mouse by the tail and place it on the rod, facing away from the operator. Repeat for the second through the fourth mouse. If a mouse falls or jumps, place it back in its lane on the Rotarod until all mice are in position. Ignore if any mice turn around to face the operator.</li>
		<li>After loading all the mice, press the &#34;Enter&#34; button to start the experiment. Observe the timers start automatically and the rotations per min (rpm) on display for each lane.
		<ol>
			<li>As each animal falls from the rod, record the speed of the rod at the time of the fall, as well as the duration of time the animal remained on the rod. The rod will continue to rotate until the last animal has fallen from the rod assembly.</li>
		</ol>
		</li>
		<li>After all the mice have fallen, use a tissue to remove any fecal boli and urine from the rod. The presence of urine and fecal material may affect the ability of mice to grip the rod.
		<ol>
			<li>After a 3-min rest, give the mice a second and then a third trial. The maximum time per single trial is 240 sec. Administer a total of 3 trials during each testing day.</li>
		</ol>
		</li>
		<li>Return the mice to their home cage and return them back to the rack. At the end of the experimental session, clean the Rotarod with soap and water to remove all fecal matter off the machine.</li>
		<li>Wipe clean the baseplate with ethanol 70%. Spray down the whole machine with chlorine dioxide to disinfect.</li>
		<li>On days - 4, - 3, - 2, and - 1 pi, pre-set the Rotarod with the appropriate training protocol parameters, as described in Table 1, and repeat steps 2.1.2 to 2.1.12.</li>
		<li>After obtaining the baseline measures, infect the mice with TMEV. Allow a 6-day pi recovery period.</li>
	</ol>
	</li>
</ol>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td rowspan="2">Protocol</td>
			<td rowspan="2">Testing Day</td>
			<td rowspan="2">Frequency</td>
			<td rowspan="2">Starting speed (rpm)</td>
			<td rowspan="2">Max Speed (rpm)</td>
			<td>Acceleration</td>
			<td>Trials</td>
			<td>ITI</td>
		</tr>
		<tr>
			<td>(rpm/sec)</td>
			<td>(N x sec)</td>
			<td>(min)</td>
		</tr>
		<tr>
			<td rowspan="4">Training</td>
			<td>- 5 d.p.i</td>
			<td>1/day</td>
			<td>1</td>
			<td>12</td>
			<td>01/03</td>
			<td>3x240 sec</td>
			<td>3</td>
		</tr>
		<tr>
			<td>- 4 d.p.i</td>
			<td>1/day</td>
			<td>1</td>
			<td>13</td>
			<td>01/03</td>
			<td>3x240 sec</td>
			<td>3</td>
		</tr>
		<tr>
			<td>- 3 d.p.i</td>
			<td>1/day</td>
			<td>1</td>
			<td>14</td>
			<td>01/03</td>
			<td>3x240 sec</td>
			<td>3</td>
		</tr>
		<tr>
			<td>- 2; - 1 d.p.i</td>
			<td>1/day</td>
			<td>5</td>
			<td>40</td>
			<td>01/03</td>
			<td>3x240 sec</td>
			<td>3</td>
		</tr>
		<tr>
			<td rowspan="2">Experimental</td>
			<td>From +7 to +50 d.p.i</td>
			<td>2/week</td>
			<td>5</td>
			<td>40</td>
			<td>05/30</td>
			<td>3x240 sec</td>
			<td>3</td>
		</tr>
		<tr>
			<td>From +51 to +150 d.p.i</td>
			<td>1/week</td>
			<td>5</td>
			<td>40</td>
			<td>05/30</td>
			<td>3x240 sec</td>
			<td>3</td>
		</tr>
	</tbody>
</table>
Table 1: Rotarod Parameters in Training and Experimental Protocols.
<ol start="2">
	<li>The Rotarod Experimental Protocol
	<ol>
		<li>On +7 dpi, pre-set the Rotarod with the appropriate experimental protocol parameters, as described in Table 1. Repeat steps 2.1.2 to 2.1.10.</li>
		<li>At the end of trial #3, weigh each mouse and make a note of the body weight on the data sheet. Clean and disinfect the Rotarod as per steps 2.1.11 and 2.1.12.</li>
		<li>Test the mice twice a week for the following 6 weeks, as described above. After 6 weeks (in which the mice have likely reached a plateau phase)8,9, test the mice once a week with the same experimental protocol. The actual testing protocol lasts an average of 150 days, depending on the specific disease course.</li>
	</ol>
	</li>
	<li>Neurological Functional Index
	<ol>
		<li>Export the raw data into a spreadsheet file and analyze the results.</li>
		<li>Express data as running time (Figure 3A): this is the normal running time plus the passive rotation time minus the rotation delay time (Table 2)10. Calculate the mean running time of the three trials per day.</li>
		<li>Express the data as a neurological functional index (NFI; Figure 3B).
		<ol>
			<li>Calculate the baseline performance threshold of each individual mouse. The baseline performance threshold is determined as the mean of all running times from day + 15 to + 45 pi6,7.</li>
			<li>Calculate the NFI as the mean of the three most recent average running times divided by the baseline performance threshold of that specific mouse6,7. 
			NOTE: If the tested running times for a mouse on day + 72, + 76, and + 79 pi are 55 sec, 45 sec, and 50 sec, and the baseline time for the same mouse was 135 sec, the NFI for that mouse on +79 dpi will be [(45+50+55)/3]/135 or 0.37.</li>
		</ol>
		</li>
		<li>Express the data as an adjusted NFI (adjNFI; Figure 3C): adjust the NFI data by a population value for the single experiment.
		<ol>
			<li>Calculate the adjNFI by dividing the NFI value by the average NFI obtained by the sham-treated group on that specific day.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Term</td>
			<td>Definition</td>
		</tr>
		<tr>
			<td>Normal running time</td>
			<td>The total time the mouse spends actively running on the rotating rod, i.e., latency to fall.</td>
		</tr>
		<tr>
			<td>Passive rotation time</td>
			<td>The amount of time the mouse has remained on the rod in the passive rotation mode.</td>
		</tr>
		<tr>
			<td>Rotation delay time</td>
			<td>The amount of time the mouse remains on the rod during the passive rotation mode</td>
		</tr>
		<tr>
			<td>Passive rotation mode</td>
			<td>When the mouse grabs the rod and rotates without having to ambulate.</td>
		</tr>
		<tr>
			<td>Total session time</td>
			<td>Total amount of time the mouse remains on the rotating rod during the session.</td>
		</tr>
		<tr>
			<td>Baseline performance</td>
			<td>Pre-damage motor performance assessed to determine the minimum performance threshold.</td>
		</tr>
		<tr>
			<td>Neurological function index (NFI)</td>
			<td>Clinical index, which compares each mouse motor performance, i.e., running time, at any time to its peak performance.</td>
		</tr>
		<tr>
			<td>Adjusted neurological function index (adjNFI)</td>
			<td>When a normalization process is applied to adjust NFI data by a population value for the single experiment.&#160;</td>
		</tr>
		<tr>
			<td>Population value</td>
			<td>Average NFI value obtained by the sham-treated group at a specific day.</td>
		</tr>
	</tbody>
</table>
Table 2: Definitions of Rotarod Parameters Adopted to Quantify Neurological Impairment.

<ol><li>Lipton, H. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Theiler%27s+virus+infection+in+mice%3A+an+unusual+biphasic+disease+process+leading+to+demyelination%5BTitle%5D)+AND+%22Infect+Immun%22%5BJournal%5D)">Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.</a> Infect Immun. 11, 1147-1155 (1975).</li>
<li>Pachner, A. R. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aPachner%2C+AR+%22A+Primer+of+Neuroimmunological+Disease%22">A Primer of Neuroimmunological Disease</a>. , Springer. New York. (2012).</li>
<li>Rustay, N. R., Wahlsten, D., Crabbe, J. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessment+of+genetic+susceptibility+to+ethanol+intoxication+in+mice%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+U+S+A%22%5BJournal%5D)">Assessment of genetic susceptibility to ethanol intoxication in mice.</a> Proc Natl Acad Sci U S A. 100, 2917-2922 (2003).</li>
<li>McGavern, D. B., Zoecklein, L., Drescher, K. M., Rodriguez, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Quantitative+assessment+of+neurologic+deficits+in+a+chronic+progressive+murine+model+of+CNS+demyelination%5BTitle%5D)+AND+%22Exp+Neurol%22%5BJournal%5D)">Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination.</a> Exp Neurol. 158, 171-181 (1999).</li>
<li>Zoecklein, L. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Direct+comparison+of+demyelinating+disease+induced+by+the+Daniel%27s+strain+and+BeAn+strain+of+Theiler%27s+murine+encephalomyelitis+virus%5BTitle%5D)+AND+%22Brain+Pathol%22%5BJournal%5D)">Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.</a> Brain Pathol. 13, 291-308 (2003).</li>
<li>Gilli, F., Li, L., Campbell, S. J., Anthony, D. C., Pachner, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+effect+of+B-cell+depletion+in+the+Theiler%27s+model+of+multiple+sclerosis%5BTitle%5D)+AND+%22J+Neurol+Sci%22%5BJournal%5D)">The effect of B-cell depletion in the Theiler's model of multiple sclerosis.</a> J Neurol Sci. 359, 40-47 (2015).</li>
<li>Li, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+effect+of+FTY720+in+the+Theiler%27s+virus+model+of+multiple+sclerosis%5BTitle%5D)+AND+%22J+Neurol+Sci%22%5BJournal%5D)">The effect of FTY720 in the Theiler's virus model of multiple sclerosis.</a> J Neurol Sci. 308, 41-48 (2011).</li>
<li>Homanics, G. E., Quinlan, J. J., Firestone, L. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pharmacologic+and+behavioral+responses+of+inbred+C57BL%2F6J+and+strain+129%2FSvJ+mouse+lines%5BTitle%5D)+AND+%22Pharmacol+Biochem+Be%22%5BJournal%5D)">Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines.</a> Pharmacol Biochem Be. 63, 21-26 (1999).</li>
<li>Balkaya, M., Krober, J. M., Rex, A., Endres, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessing+post-stroke+behavior+in+mouse+models+of+focal+ischemia%5BTitle%5D)+AND+%22J+Cerebr+Blood+F+Met%22%5BJournal%5D)">Assessing post-stroke behavior in mouse models of focal ischemia.</a> J Cerebr Blood F Met. 33, 330-338 (2013).</li>
<li><a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=%22Columbus+Instruments+Rotamex-5+Manual%22">Columbus Instruments Rotamex-5 Manual</a>. , 1-33 (2005).</li>
<li>Dunham, N. W., Miya, T. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+note+on+a+simple+apparatus+for+detecting+neurological+deficit+in+rats+and+mice%5BTitle%5D)+AND+%22J+Am+Pharm+Ass%22%5BJournal%5D)">A note on a simple apparatus for detecting neurological deficit in rats and mice.</a> J Am Pharm Ass. 46, 208-209 (1957).</li>
<li>Ulrich, R., Kalkuhl, A., Deschl, U., Baumgartner, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Machine+learning+approach+identifies+new+pathways+associated+with+demyelination+in+a+viral+model+of+multiple+sclerosis%5BTitle%5D)+AND+%22J+Cell+Mol+Med%22%5BJournal%5D)">Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis.</a> J Cell Mol Med. 14, 434-448 (2010).</li>
<li>Lynch, J. L., Gallus, N. J., Ericson, M. E., Beitz, A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Analysis+of+nociception%2C+sex+and+peripheral+nerve+innervation+in+the+TMEV+animal+model+of+multiple+sclerosis%5BTitle%5D)+AND+%22Pain%22%5BJournal%5D)">Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis.</a> Pain. 136, 293-304 (2008).</li>
<li>Pirko, I., Johnson, A. J., Lohrey, A. K., Chen, Y., Ying, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deep+gray+matter+T2+hypointensity+correlates+with+disability+in+a+murine+model+of+MS%5BTitle%5D)+AND+%22J+Neurol+Sci%22%5BJournal%5D)">Deep gray matter T2 hypointensity correlates with disability in a murine model of MS.</a> J Neurol Sci. 282, 34-38 (2009).</li>
<li>Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Theiler%27s+virus+infection%3A+a+model+for+multiple+sclerosis%5BTitle%5D)+AND+%22Clin+Microbiol+Rev%22%5BJournal%5D)">Theiler's virus infection: a model for multiple sclerosis.</a> Clin Microbiol Rev. 17, 174-207 (2004).</li>
<li>McCarthy, D. P., Richards, M. H., Miller, S. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mouse+models+of+multiple+sclerosis%3A+experimental+autoimmune+encephalomyelitis+and+Theiler%27s+virus-induced+demyelinating+disease%5BTitle%5D)+AND+%22Methods+Mol+Biol%22%5BJournal%5D)">Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.</a> Methods Mol Biol. 900, Clifton, N.J. 381-401 (2012).</li>
<li>International Mouse Phenotyping Resource of Standardised Screens. , Available from:
 Rotarod. https://www.mousephenotype.org/impress/protocol/158/12 (2016).</li>
<li>Bohlen, M., Cameron, A., Metten, P., Crabbe, J. C., Wahlsten, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Calibration+of+rotational+acceleration+for+the+rotarod+test+of+rodent+motor+coordination%5BTitle%5D)+AND+%22J+Neurosci+Methods%22%5BJournal%5D)">Calibration of rotational acceleration for the rotarod test of rodent motor coordination.</a> J Neurosci Methods. 178, 10-14 (2009).</li>
<li>Hopkins, M. E., Bucci, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Interpreting+the+effects+of+exercise+on+fear+conditioning%3A+the+influence+of+time+of+day%5BTitle%5D)+AND+%22Behav+Neurosci%22%5BJournal%5D)">Interpreting the effects of exercise on fear conditioning: the influence of time of day.</a> Behav Neurosci. 124, 868-872 (2010).</li>
</ol>

The authors have nothing to disclose.

Despite some limitations, the Rotarod performance test represents an important tool for assessing motor function and dysfunction in TMEV-IDD as well as the effect of pharmacological interventions on disability progression in mice.
The Rotarod test was first described in 1957 as a tool for measuring neurological deficits in rodents11. Rodents have to walk on a rotating rod, with increasing rotating speed, and try to avoid falling to the ground. The latency to fall is recorded and use...

Theiler&#39;s Murine Encephalomyelitis Virus (TMEV) is a neurotropic single-stranded RNA virus that persistently infects the murine central nervous system (CNS). In susceptible mice, infection with TMEV causes an immune-mediated, chronic-progressive demyelinating disease, known as TMEV-induced demyelinating disease (TMEV-IDD). Experimental infection of mice takes a disease course resembling that seen in progressive forms of multiple sclerosis (MS). TMEV-IDD is characterized by two distinct phases: the acute phase and the chronic phase. The acute phase is a mild, usually subclinical encephalitis1,2. The second, chronic phase, beginning about a month after infection, consists of a slowly progressing disability characterized by demyelination, inflammation, and axonal damage1,2. The weakness observed in mice is associated with spasticity and, occasionally, severe tonic spasms.
Because there are currently no medications to ameliorate the progressive disability in patients, researchers are particularly attracted by TMEV-IDD, which represents an optimal animal model for monitoring the impact of disease-modifying drugs on disease progression. However, in mice as well as in MS patients, the monitoring of disability progression requires a continuous clinical observation over extended periods of time. In mice, long-term monitoring for disability progression can be accomplished with the Rotarod performance test.
The Rotarod performance test is a standard behavioral test that evaluates motor-associated functions such as coordination, balance, and fatigue in rodents. The mice have to keep their balance on a turning rod, which is rotating under continuous acceleration; the time latency to fall from this rod is recorded. Animals with neurological dysfunction are unable to stay on the rotating rod as long as controls, and they normally drop off when the rotation speed exceeds their motor capacity. The more neurological impairment the animals have, the sooner they fall off the rod, and the shorter the time latency is.
The advantage of the Rotarod test over the traditional visual scoring systems is that it generates an objective, measurable variable-the time latency-which can ultimately be used for statistical analyses to quantify the effects of therapies and experimental procedures3.
In the Laboratory of Neuroimmunology (LONI) at Dartmouth, mice are subjected to an adaptation protocol, where they are tested prior to TMEV infection in order to familiarize them with the machine and to assess their normal &#34;baseline&#34; balance coordination and motor control4,5. Once the baseline is established and the mice are infected with TMEV, they are tested once or twice a week over a period of several months. The actual testing protocol lasts an average of 150 days, thus allowing an assessment of the decline of balance, coordination, and motor control over the entire course of the demyelinating disease.
Several hundred TMEV-IDD and sham-treated mice have been tested so far for neurological dysfunction at Dartmouth. These mice had received various immunomodulatory treatments, but no pharmacological agent has been found to be effective in ameliorating disability progression6,7. The present article and the related protocol describe how to characterize the progressive neurological impairment displayed by TMEV-IDD mice. Particularly, the protocol offers recommendations of specific testing parameters believed to be generally suitable for studying neurological disability in TMEV-IDD mice using the Rotarod test. This procedure provides a baseline against which to assess (1) the relevance of this mouse model to progressive MS and (2) its usefulness for testing therapies aimed at treating progressive neurological conditions such as MS. Clearly, the Rotarod performance test and the current optimized testing parameters and protocol are not only useful at detecting progressive neurological disability in the TMEV-IDD mouse model, but are also useful in uncovering impairments in other virus-induced and/or genetic mouse models of neurodegenerative diseases.

<table><tbody><tr><td>Mice SJL/JCrHsd 4 to 6 weeks old</td><td>Envigo</td><td>#052</td><td></td></tr><tr><td>TMEV virus stock</td><td></td><td></td><td></td></tr><tr><td>Isoflurane vaporizer</td><td>Harvard Apparatus</td><td>#340471</td><td></td></tr><tr><td>Insulin Syringes U- 100 29 g x 0.5 cc</td><td>BD</td><td>#328203</td><td></td></tr><tr><td>Rotamex-5 4 Lane Rota-Rod for Mice with RS-232 and Software</td><td>Columbus Instruments</td><td>#0890M</td><td></td></tr></tbody></table>

measuring progressive neurological disability in a mouse model of multiple sclerosis

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

After intracerebral infection with the Theiler's Murine Encephalomyelitis Virus (TMEV), susceptible SJL mice develop a chronic-progressive demyelinating disease, with clinical features similar to the progressive forms of multiple sclerosis (MS). The mice show progressive disability with loss of motor and sensory functions, which can be assessed with multiple apparatuses and protocols. Among them, the Rotarod performance test is a very common behavioral test, its advantage being that it provides objective measurements, but it is often used assuming that it is straightforward and simple. In contrast to visual scoring systems used in some models of MS, which are highly subjective, the Rotarod test generates an objective, measurable, continuous variable (i.e., length of time), allowing almost perfect inter-rater concordances. However, inter-laboratory reliability is only achieved if the various testing parameters are replicated. In this manuscript, recommendations of specific testing parameters, such as size, speed, and acceleration of the rod; amount of training given to the animals; and data processing, are presented for the Rotarod test.

The aim of this representative experiment was to compare the neurological disability induced by the Daniels (DA) strain and BeAn strain of TMEV. For the purposes of the present study, a group of 32 female SJL mice were infected intracranially with TMEV, either the DA strain (n = 16) or the BeAn strain (n = 16), and their clinical signs were monitored over time. An additional group of 20 mice was sham treated (i.e., saline solution was injected intracranially) and served as health...

An optimized testing protocol is presented in this paper for the Rotarod performance test, used for measuring progressive neurological disability in TMEV-infected mice.

After intracerebral infection with the Theiler's Murine Encephalomyelitis Virus (TMEV), susceptible SJL mice develop a chronic-progressive demyelinating ...

The overall goal of this procedure is to assess the progressive neurological impairment in mice with chronic demyelinating diseases. We accomplish this by offering recommendations of testing parameters suitable for studying long term neurological disability in the Theilers virus model of progressive multiple sclerosis, using the Rotarod test. This procedure provides a baseline against which to assess the relevance of mouse model to progressive demyelination and it's usefulness for testing therapies aimed at treating progressive neurological condition such as multiple sclerosis.The advantage of this optimized test over the traditional visual scoring system is that it generates an objective variable to quantify the long term effect of therapies and experimental procedures on motor functions. Demonstrating this procedure will be Darlene Royce, a technician from the laboratory of neuroimmunology at Dartmouth. In order to assess baseline balance coordination and motor control, start the adaption protocol five days prior to TMEV infection by first allowing the mice to acclimate to the testing room for at least 30 minutes.While the mice are acclimating, preset the Rotarod with the minus five DPI training parameters. Then, pickup a mouse by the tail and place it on the rod facing away from the operator. If the mouse falls or jumps, place it back in its lane on the Rotarod until all mice are in position.After loading all four mice, press the enter button to start the experiment. Ensure that the timers start automatically, and observe the rotations per minutes on display for each lane. Then, as each animal falls from the rod, record the speed of the rod at the time of the fall, as well as the duration of time the animal remained on the rod.After all the mice have fallen, use a tissue to remove any fecal boli and urine from the rod as the presence of urine and fecal material may affect the ability of mice to properly grip the rod. After a three minute rest give the mice a second and then a third trial in which the maximum time per single trial is 240 seconds. Administer a total of three trials during each testing day.Finally, return the mice to their home cage. On days negative four, negative three, negative two, and negative one PI, preset the Rotarod with the appropriate training protocol parameters and repeat the Rotarod experiment. Begin by moving cages containing four to six week old female SJL mice from the rack to a comfortable working space.Use ear punches to mark the mice to allow for individual evaluation of clinical and histological disease. Next, draw 30 microliters of TMEV infecting stock in PBS into a 29 gauge insulin syringe needle. Prepare the anesthesia gas machine by ensuring the presence of adequate amounts of oxygen and isoflurane for the duration of the procedure.Place the animal into the induction chamber and seal the top. After a few minutes, remove the animal from the chamber, and test the mouse by pinching the foot pad to ensure adequate anesthesia. Next, clean the injection site with 70%isopropyl alcohol and inject the 30 microliters of TMEV infecting stock into the right cerebral hemisphere by freehand injection.Finally, return the mouse to its holding cage once it is fully alert and mobile. On day seven post infection, preset the Rotarod with the appropriate experimental parameters, and repeat the complete Rotarod training excercise with the appropriate experimental protocol parameters. After the third trial on each day, weigh each mouse and make a note of the body weight on the data sheet.Test the mice twice a week for the following six weeks in the same manner. After six weeks, test the mice once a week with the same experimental protocol for an average of 150 experimental days. Next, analyze the raw data, and express as a neurological functional index, or NFI.To determine the individual NFI value, calculate the baseline performance threshold of each mouse as the mean of all running times from 15 to 45 days post infection. In order to allow for the evaluation of motor performance as a result of progressive demyelination and exclude any contributing deficits due to early encephalitis. Then, calculate the NFI value as the mean of the three most recent average running times divided by the baseline performance threshold of the mouse.Finally, calculate an adjusted NFI by dividing the NFI value by the average NFI value obtained by the sham treated group on that specific day. This figure shows the TMEV infected mice display significantly increased neurological deficits over time when compared with control mice. Chronic infection with two different strains of TMEV negatively affected the running times of the mice.Both groups of TMEV infected mice had significantly lower NFI values than those of sham mice. Furthermore, there was no difference comparing disability progression in mice infected with the BeAn strain, and those infected with the DA strain at all time points. Following this procedure are the traditional visual scoring methods, like the righting reflex test, can be performed in order to rapidly assess general health in mice.After its development, this technique paved the way for researchers in the field of multiple sclerosis and neurodegenerative diseases to test the effectiveness of therapies and other intervention in delaying progressive disability. After watching this video, you should have a good understanding of how to evaluate the long term progressive disability in mice. This procedure is not only useful in detecting the progressive neurological disability in the Theiler virus model, but is also useful in uncovering impairments in other mouse models of neurodegenerative diseases.

measuring-progressive-neurological-disability-mouse-model-multiple

Research

JoVE Journal

Neuroscience

Protocols are presented for two established motor coordination tasks, the accelerating rotarod and horizontal bar, also two tests developed in Oxford recently, the static rods and parallel bars. These tests can detect motor impairments potentially of interest in their own right, as well as being possible variables in tests of other areas of behavior.

Measuring Motor Coordination in Mice

A mouse model for amyotrophic lateral sclerosis (ALS) is examined clinically and behaviorally. As a prerequisite for an accompanying immunohistological analysis the preparation of the spinal cord is depicted in detail.

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

Precise measurement of neurological and neuropsychological impairment and disability in multiple sclerosis is challenging. We report methodologic details on a new test, the Multiple Sclerosis Performance Test (MSPT). This new approach to the objective of quantification of MS related disability provides a computer-based platform for precise, valid measurement of MS severity.

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

This video protocol describes a sensitive, reliable, and quick method for evaluating the neuromuscular deficits in a transgenic mouse model of amyotrophic lateral sclerosis.

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

We show a technique for in vivo live bioluminescence and near-infrared imaging of optic neuritis and encephalitis in the experimental autoimmune encephalomyelitis (EAE) model for multiple sclerosis in SJL/J mice.

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Kinematic gait analysis in the sagittal plane yields highly precise information about how movement is executed. We describe the application of these techniques to identify gait deficits for mice subjected to autoimmune-mediated demyelination. These methods may also be used to characterize gait deficits for other mouse models featuring impaired locomotion.

Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis

The measurement of nerve conduction is a useful tool to assess mouse models of neurodegeneration but it is frequently only applied to stimulate the sciatic nerve in hindlimbs. Here, we describe a technique to measure compound muscle action potential (CMAP) in vivo in the mouse forelimb muscles innervated by the brachial plexus.

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

An experimental pipeline to quantitatively describe the locomotor pattern of freely walking mice using the MouseWalker (MW) toolbox is provided, ranging from initial video recordings and tracking to post-quantification analysis. A spinal cord contusion injury model in mice is employed to demonstrate the usefulness of the MW system.

Using the MouseWalker to Quantify Locomotor Dysfunction in a Mouse Model of Spinal Cord Injury

Experimental autoimmune encephalomyelitis (EAE) serves as an animal model of multiple sclerosis. This article describes an approach for scoring spinal cord inflammation, demyelination, and axonal injury in EAE. Additionally, a method to quantify soluble neurofilament light levels in the mice serum is presented, facilitating the assessment of axonal injury in live mice.

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Experimental autoimmune encephalomyelitis is one of the most widely used murine models of multiple sclerosis. In the current protocol, C57BL/6J mice of both sexes are immunized with myelin oligodendrocyte glycoprotein peptide, resulting mainly in ascending paresis of the tail and limbs. Here we discuss the protocol of EAE induction and evaluation.

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

This article presents a protocol for executing the highly translational and independently proven mouse Stroke Unit (mSU) concept in large-stroke mice. It also provides a standardized protocol for executing the focal experimental stroke scale in mice, which evaluates stroke focal deficits detected even long-term.

The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies

Learn to assess progressive neurological disability in mice using an optimized Rotarod test protocol. This method provides objective quantification of motor function in the Theilers virus model of multiple sclerosis.

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Explore More Videos